Rafferty Asset Management, LLC Q2 2021 Filing
Filed August 10, 2021
Portfolio Value
$15.9B
Holdings
1,253
Report Date
Q2 2021
Filing Type
13F-HR
All Holdings (1,253 positions)
| Stock | Value |
|---|---|
RNGRINGCENTRAL INC | $3.0B |
CTXSEURCITRIX SYS INC | $3.0B |
IBKRINTERACTIVE BROKERS GROUP IN | $3.0B |
MVISMICROVISION INC DEL | $3.0B |
PRGSPROGRESS SOFTWARE CORP | $3.0B |
PANWPALO ALTO NETWORKS INC | $2.9B |
KODKODIAK SCIENCES INC | $2.9B |
EBCEASTERN BANKSHARES INC | $2.9B |
DXCDXC TECHNOLOGY CO | $2.9B |
IOVAIOVANCE BIOTHERAPEUTICS INC | $2.9B |
VCYTVERACYTE INC | $2.9B |
INSGEURINSEEGO CORP | $2.9B |
RCUSARCUS BIOSCIENCES INC | $2.9B |
TYLTYLER TECHNOLOGIES INC | $2.9B |
CCXIEURCHEMOCENTRYX INC | $2.9B |
ORGOORGANOGENESIS HLDGS INC | $2.9B |
MGYMAGNOLIA OIL & GAS CORP | $2.9B |
IRWDIRONWOOD PHARMACEUTICALS INC | $2.9B |
NTRANATERA INC | $2.9B |
NFENEW FORTRESS ENERGY INC | $2.9B |
SRNESORRENTO THERAPEUTICS INC | $2.9B |
FEYECHFFIREEYE INC | $2.8B |
OPKOPKO HEALTH INC | $2.8B |
—SESEN BIO INC | $2.8B |
—PLANTRONICS INC NEW | $2.8B |
NVTA1EURINVITAE CORP | $2.8B |
SBACSBA COMMUNICATIONS CORP NEW | $2.8B |
NYCBEURNEW YORK CMNTY BANCORP INC | $2.8B |
UBSIUNITED BANKSHARES INC WEST V | $2.8B |
DVAXDYNAVAX TECHNOLOGIES CORP | $2.8B |
RLAYRELAY THERAPEUTICS INC | $2.8B |
LGNDLIGAND PHARMACEUTICALS INC | $2.8B |
HALOHALOZYME THERAPEUTICS INC | $2.8B |
ERIEERIE INDTY CO | $2.7B |
ISIIONIS PHARMACEUTICALS INC | $2.7B |
THGHANOVER INS GROUP INC | $2.7B |
ARNAEURARENA PHARMACEUTICALS INC | $2.7B |
DNLIDENALI THERAPEUTICS INC | $2.7B |
STXSEAGATE TECHNOLOGY HLDNGS PL | $2.7B |
CCSCENTURY CMNTYS INC | $2.7B |
—TURNING POINT THERAPEUTICS I | $2.7B |
CBUCOMMUNITY BK SYS INC | $2.7B |
MMM3M CO | $2.7B |
VENVENTAS INC | $2.7B |
VIRVIR BIOTECHNOLOGY INC | $2.7B |
DCPHEURDECIPHERA PHARMACEUTICALS IN | $2.7B |
ALTOALTO INGREDIENTS INC | $2.7B |
MYGNMYRIAD GENETICS INC | $2.7B |
ALNYALNYLAM PHARMACEUTICALS INC | $2.7B |
TGTXTG THERAPEUTICS INC | $2.7B |
DMTKQDERMTECH INC | $2.7B |
FGENEURFIBROGEN INC | $2.7B |
ETSYETSY INC | $2.7B |
APLSAPELLIS PHARMACEUTICALS INC | $2.7B |
IMGNEURIMMUNOGEN INC | $2.7B |
BMRNBIOMARIN PHARMACEUTICAL INC | $2.7B |
GTHXEURG1 THERAPEUTICS INC | $2.6B |
CVCOCAVCO INDS INC DEL | $2.6B |
NVV1NOVAVAX INC | $2.6B |
2L9BLUEPRINT MEDICINES CORP | $2.6B |
AJRDEURAEROJET ROCKETDYNE HLDGS INC | $2.6B |
REPLREPLIMUNE GROUP INC | $2.6B |
HRTXHERON THERAPEUTICS INC | $2.6B |
—CURIS INC | $2.6B |
—MYOVANT SCIENCES LTD | $2.6B |
TCE2CELLDEX THERAPEUTICS INC NEW | $2.6B |
CHRDOASIS PETROLEUM INC | $2.6B |
LPXLOUISIANA PAC CORP | $2.6B |
CLVSEURCLOVIS ONCOLOGY INC | $2.6B |
HZNPHORIZON THERAPEUTICS PUB L | $2.6B |
CDNACAREDX INC | $2.6B |
SWTXSPRINGWORKS THERAPEUTICS INC | $2.6B |
UTHUNITED THERAPEUTICS CORP DEL | $2.6B |
BABAALIBABA GROUP HLDG LTD | $2.6B |
LAZLAZARD LTD | $2.6B |
KPTIEURKARYOPHARM THERAPEUTICS INC | $2.6B |
ALLOALLOGENE THERAPEUTICS INC | $2.6B |
—DICERNA PHARMACEUTICALS INC | $2.6B |
MTGMGIC INVT CORP WIS | $2.6B |
PINGUSDPING IDENTITY HLDG CORP | $2.6B |
RITMNEW RESIDENTIAL INVT CORP | $2.6B |
EBSEMERGENT BIOSOLUTIONS INC | $2.6B |
KTOSKRATOS DEFENSE & SEC SOLUTIO | $2.6B |
—BLUEBIRD BIO INC | $2.6B |
NBIXNEUROCRINE BIOSCIENCES INC | $2.6B |
ZTSZOETIS INC | $2.6B |
EGHT8X8 INC NEW | $2.6B |
LINLINDE PLC | $2.6B |
PTCTPTC THERAPEUTICS INC | $2.6B |
ALKSALKERMES PLC | $2.6B |
UI2KEMPER CORP | $2.6B |
LF2PACIFIC PREMIER BANCORP | $2.5B |
GEGENERAL ELECTRIC CO | $2.5B |
DKDELEK US HLDGS INC NEW | $2.5B |
FATEFATE THERAPEUTICS INC | $2.5B |
HOMBHOME BANCSHARES INC | $2.5B |
KYMRKYMERA THERAPEUTICS INC | $2.5B |
GBYSANGAMO THERAPEUTICS INC | $2.5B |
RCKTROCKET PHARMACEUTICALS INC | $2.5B |
XRXXEROX HOLDINGS CORP | $2.5B |